Insider Buy/Sell Details for the Healthcare Sector — April 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1406)
PTC THERAPEUTICS, INC. (PTCT)
Almstead Neil Gregory — CHIEF TECHNICAL OPS OFFICER
Shares
80
Price
$70.30
Total Value
$5.62K
Shares Held After
60,137
% of Holdings
0.1%
PTC THERAPEUTICS, INC. (PTCT)
Almstead Neil Gregory — CHIEF TECHNICAL OPS OFFICER
Shares
12,530
Price
$69.50
Total Value
$870.84K
Shares Held After
60,217
% of Holdings
17.2%
PTC THERAPEUTICS, INC. (PTCT)
Almstead Neil Gregory — CHIEF TECHNICAL OPS OFFICER
Shares
39,393
Price
$68.89
Total Value
$2.71M
Shares Held After
72,747
% of Holdings
35.1%
Arcutis Biotherapeutics, Inc. (ARQT)
Welgus Howard G. — Director
Shares
10,000
Price
$23.88
Total Value
$238.80K
Shares Held After
39,744
% of Holdings
20.1%
Xeris Biopharma Holdings, Inc. (XERS)
Hecht Beth — Chief Legal Officer and Corporate Secretary
Shares
16,667
Price
$5.99
Total Value
$99.86K
Shares Held After
1,209,840
% of Holdings
1.4%
SI-BONE, Inc. (SIBN)
PISETSKY MICHAEL A. — SVP, Ops & Adm/Chief Legal Ofr
Shares
1,799
Price
$12.95
Total Value
$23.30K
Shares Held After
284,175
% of Holdings
0.6%
Heartflow, Inc. (HTFL)
Rogers Campbell — Chief Medical Officer
Shares
64,533
Price
$24.64
Total Value
$1.59M
Shares Held After
81,002
% of Holdings
44.3%
Tectonic Therapeutic, Inc. (TECX)
Ruddy Marcella K. — Chief Medical Officer
Shares
1,000
Price
$31.05
Total Value
$31.05K
Shares Held After
68,747
% of Holdings
1.4%
Sight Sciences, Inc. (SGHT)
Taylor Brenton — EVP, Operations & R&D
Shares
2,869
Price
$3.70
Total Value
$10.62K
Shares Held After
267,807
% of Holdings
1.1%
Sight Sciences, Inc. (SGHT)
Badawi Paul — Director
Shares
29,244
Price
$3.70
Total Value
$108.20K
Shares Held After
6,151,156
% of Holdings
0.5%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Liu Joy — EVP and Chief Legal Officer
Shares
978
Price
$449.17
Total Value
$439.29K
Shares Held After
21,833
% of Holdings
4.3%
Jazz Pharmaceuticals plc (JAZZ)
COZADD BRUCE C — Director
Shares
24
Price
$191.74
Total Value
$4.60K
Shares Held After
384,682
% of Holdings
0.0%
Jazz Pharmaceuticals plc (JAZZ)
COZADD BRUCE C — Director
Shares
2,292
Price
$190.94
Total Value
$437.63K
Shares Held After
384,706
% of Holdings
0.6%
Jazz Pharmaceuticals plc (JAZZ)
COZADD BRUCE C — Director
Shares
3,684
Price
$190.22
Total Value
$700.78K
Shares Held After
386,998
% of Holdings
0.9%
Nuvalent, Inc. (NUVL)
Balcom Alexandra — Chief Financial Officer
Shares
2,469
Price
$106.18
Total Value
$262.16K
Shares Held After
85,533
% of Holdings
2.8%
Nuvalent, Inc. (NUVL)
Balcom Alexandra — Chief Financial Officer
Shares
5,417
Price
$105.30
Total Value
$570.41K
Shares Held After
88,002
% of Holdings
5.8%
Nuvalent, Inc. (NUVL)
Balcom Alexandra — Chief Financial Officer
Shares
3,544
Price
$104.39
Total Value
$369.96K
Shares Held After
93,419
% of Holdings
3.7%
Avalo Therapeutics, Inc. (AVTX)
Doyle Mittie — Chief Medical Officer
Shares
679
Price
$16.00
Total Value
$10.86K
Shares Held After
3,622
% of Holdings
15.8%
Avalo Therapeutics, Inc. (AVTX)
Sullivan Christopher Ryan — Chief Financial Officer
Shares
7,479
Price
$16.83
Total Value
$125.84K
Shares Held After
25,318
% of Holdings
22.8%
Avalo Therapeutics, Inc. (AVTX)
Sullivan Christopher Ryan — Chief Financial Officer
Shares
500
Price
$15.86
Total Value
$7.93K
Shares Held After
32,797
% of Holdings
1.5%
Ceribell, Inc. (CBLL)
Woo Raymond — Chief Technology Officer
Shares
6,615
Price
$18.57
Total Value
$122.84K
Shares Held After
166,912
% of Holdings
3.8%
Ceribell, Inc. (CBLL)
Woo Raymond — Chief Technology Officer
Shares
3,025
Price
$18.53
Total Value
$56.05K
Shares Held After
166,912
% of Holdings
1.8%
Ceribell, Inc. (CBLL)
Woo Raymond — Chief Technology Officer
Shares
1,472
Price
$18.58
Total Value
$27.35K
Shares Held After
166,912
% of Holdings
0.9%
Neuraxis, INC (NRXS)
Henrichs Timothy Robert — Chief Financial Officer
Shares
7,593
Price
$1.96
Total Value
$14.88K
Shares Held After
7,593
% of Holdings
100.0%
Neuraxis, INC (NRXS)
Carrico Thomas Joeseph — CRO, CCO, CPO
Shares
667
Price
$1.96
Total Value
$1.31K
Shares Held After
331,903
% of Holdings
0.2%
Neuraxis, INC (NRXS)
Carrico Brian Allen — Director
Shares
8,060
Price
$1.96
Total Value
$15.80K
Shares Held After
348,178
% of Holdings
2.3%
Erasca, Inc. (ERAS)
Garner Ebun — Chief Legal Officer
Shares
80,000
Price
$16.40
Total Value
$1.31M
Shares Held After
25,076
% of Holdings
76.1%
COMPUGEN LTD (CGEN)
Levine Zurit — SVP, Business Development
Shares
3,500
Price
$2.20
Total Value
$7.70K
Shares Held After
29,375
% of Holdings
10.6%
COMPUGEN LTD (CGEN)
Ophir Eran — Director
Shares
5,625
Price
$2.21
Total Value
$12.41K
Shares Held After
11,375
% of Holdings
33.1%
RESMED INC (RMD)
Sandercock Brett — Chief Financial Officer
Shares
1,000
Price
$224.31
Total Value
$224.31K
Shares Held After
83,495
% of Holdings
1.2%
Maze Therapeutics, Inc. (MAZE)
Bachrodt Amy — SVP, Finance
Shares
300
Price
$30.34
Total Value
$9.10K
Shares Held After
12,965
% of Holdings
2.3%
Maze Therapeutics, Inc. (MAZE)
Bachrodt Amy — SVP, Finance
Shares
2,200
Price
$29.32
Total Value
$64.51K
Shares Held After
13,265
% of Holdings
14.2%
Maze Therapeutics, Inc. (MAZE)
Bernstein Harold — President, R&D & CMO
Shares
300
Price
$31.07
Total Value
$9.32K
Shares Held After
0
% of Holdings
100.0%
Maze Therapeutics, Inc. (MAZE)
Bernstein Harold — President, R&D & CMO
Shares
3,348
Price
$30.06
Total Value
$100.64K
Shares Held After
300
% of Holdings
91.8%
Maze Therapeutics, Inc. (MAZE)
Bernstein Harold — President, R&D & CMO
Shares
11,352
Price
$29.24
Total Value
$331.95K
Shares Held After
3,648
% of Holdings
75.7%
ADC Therapeutics SA (ADCT)
Redmile Group, LLC — 10% Owner
Shares
162,517
Price
$3.80
Total Value
$617.40K
Shares Held After
12,794,788
% of Holdings
1.3%
ADC Therapeutics SA (ADCT)
Redmile Group, LLC — 10% Owner
Shares
169,265
Price
$3.80
Total Value
$643.04K
Shares Held After
15,301,237
% of Holdings
1.1%
Hinge Health, Inc. (HNGE)
Mecklenburg Gabriel M.I. — Director
Shares
668
Price
$39.02
Total Value
$26.06K
Shares Held After
0
% of Holdings
100.0%
Hinge Health, Inc. (HNGE)
Mecklenburg Gabriel M.I. — Director
Shares
49,332
Price
$38.45
Total Value
$1.90M
Shares Held After
668
% of Holdings
98.7%
BRISTOL MYERS SQUIBB CO (BMY)
Elkins David V — EVP, Chief Financial Officer
Shares
4,481
Price
$62.05
Total Value
$278.05K
Shares Held After
159,248
% of Holdings
2.7%
BRISTOL MYERS SQUIBB CO (BMY)
Elkins David V — EVP, Chief Financial Officer
Shares
25,519
Price
$61.60
Total Value
$1.57M
Shares Held After
163,729
% of Holdings
13.5%
Entrada Therapeutics, Inc. (TRDA)
WENTWORTH KORY JAMES — Chief Financial Officer
Shares
2,500
Price
$12.95
Total Value
$32.38K
Shares Held After
119,010
% of Holdings
2.1%
IONIS PHARMACEUTICALS INC (IONS)
KLEIN JOSEPH III — Director
Shares
2,216
Price
$75.95
Total Value
$168.31K
Shares Held After
11,014
% of Holdings
16.7%
IONIS PHARMACEUTICALS INC (IONS)
KLEIN JOSEPH III — Director
Shares
20,105
Price
$75.50
Total Value
$1.52M
Shares Held After
13,230
% of Holdings
60.3%
LIGAND PHARMACEUTICALS INC (LGND)
KOZARICH JOHN W — Director
Shares
159
Price
$204.26
Total Value
$32.48K
Shares Held After
42,253
% of Holdings
0.4%
LIGAND PHARMACEUTICALS INC (LGND)
KOZARICH JOHN W — Director
Shares
43
Price
$202.91
Total Value
$8.73K
Shares Held After
42,412
% of Holdings
0.1%
LIGAND PHARMACEUTICALS INC (LGND)
KOZARICH JOHN W — Director
Shares
79
Price
$202.42
Total Value
$15.99K
Shares Held After
42,455
% of Holdings
0.2%
LIGAND PHARMACEUTICALS INC (LGND)
KOZARICH JOHN W — Director
Shares
40
Price
$201.24
Total Value
$8.05K
Shares Held After
42,534
% of Holdings
0.1%
LIGAND PHARMACEUTICALS INC (LGND)
KOZARICH JOHN W — Director
Shares
146
Price
$199.97
Total Value
$29.20K
Shares Held After
42,574
% of Holdings
0.3%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
19,060
Price
$14.45
Total Value
$275.42K
Shares Held After
451,540
% of Holdings
4.1%
Showing 351–400 of 1406 transactions (page 8 of 29)